Back to Trades
GORDON CARL L
Director10% OwnerCIK 0001282930
Total Volume
$69.9M
13 filings
Purchases
$65.5M
23 buy txns
Sales
$0
0 sell txns
Net Activity
$65.5M
net bought
Profile
- Filings
- 13
- Buy transactions
- 23
- Sell transactions
- 0
- Companies
- 5
- Active
- 2025–2026
Across 13 filings between 2025–2026, GORDON CARL L, Director, 10% Owner, has disclosed $69.9M in transactions — spread across 5 companies. Their disclosed trades are heavily weighted toward buying — $65.5M in buys and $0 in sells. The largest single open-market purchase on record is $20.0M in Electra Therapeutics, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
13 loaded
| Nov 10 | ETRA Electra Therapeutics, Inc. | GORDON CARL L | Director, 10% Owner | Buy | $744.5K |
| Nov 5 | ETRA Electra Therapeutics, Inc. | GORDON CARL L | Director, 10% Owner | Buy | $3.6M |
| Sep 30 | ADRX ADARx Pharmaceuticals, Inc. | GORDON CARL L | Director, 10% Owner | Buy | $16.1M |
| Sep 24 | ADRX ADARx Pharmaceuticals, Inc. | GORDON CARL L | Insider | Other | $0 |
| Sep 23 | ETRA Electra Therapeutics, Inc. | GORDON CARL L | Director, 10% Owner | Buy | $20.0M |
| Sep 18 | ETRA Electra Therapeutics, Inc. | GORDON CARL L | Insider | Other | $0 |
| Aug 12 | BLSM BlossomHill Therapeutics, Inc. | GORDON CARL L | Director | Buy | $10.0M |
| Aug 10 | BLSM BlossomHill Therapeutics, Inc. | GORDON CARL L | Insider | Award | $382.5K |
| Aug 6 | BLSM BlossomHill Therapeutics, Inc. | GORDON CARL L | Insider | Other | $0 |
| Jul 29 | SCTX Scribe Therapeutics, Inc. | GORDON CARL L | Director | Buy | $15.0M |
| Jul 27 | SCTX Scribe Therapeutics, Inc. | GORDON CARL L | Insider | Award | $220.9K |
| Jul 23 | SCTX Scribe Therapeutics, Inc. | GORDON CARL L | Insider | Other | $0 |
| Dec 18 | KROS Keros Therapeutics, Inc. | GORDON CARL L | Director | Disposed | $3.8M |
13 filings